Is Quest Diagnostics Incorporated (DGX) a Buy, Sell, or Hold?
NYSE : DGX
Quest Diagnostics Incorporated — Insider Trades
$231.84 USD
$3.98 (1.75%)
- Volume
- 959.71K
- Average Volume
- 920.83K
- Market Capitalization
- $25.59B
- P/E Ratio
- 24.30
- Dividend Yield
- 1.43%
- Price Target
- $235.00
- Year High
- $237.78
- Year Low
- $165.78
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.34
- Current Ratio
- $1.59
Insider Activity Summary (Last 12 Months)
Insiders Buying
66
Insiders Selling
65
Amount of Insider Selling
$326.51K
DGX Insider Buying/Selling by Quarter
DGX Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| KUPPUSAMY KARTHIK | officer: SVP, Clinical Solutions | 2026-07-22 | L-Small | 206.807 | 2026-07-27 |
| CARTER ROBERT B | director | 2026-07-22 | L-Small | 206.804 | 2026-07-27 |
| Gregg Vicky B | director | 2026-07-22 | A-Award | 206.808 | 2026-07-27 |
| Plewman Patrick | officer: SVP for Diagnostic Services | 2026-07-22 | L-Small | 206.807 | 2026-07-27 |
| MAIN TIMOTHY L | director | 2026-07-22 | L-Small | 206.81 | 2026-07-27 |
| SAMAD SAM | officer: Executive Vice President & CFO | 2026-07-22 | A-Award | 206.807 | 2026-07-27 |
| Lassiter Wright III | director | 2026-07-22 | L-Small | 206.813 | 2026-07-27 |
| DELANEY MARK E | officer: SVP & Chief Commercial Officer | 2026-07-22 | L-Small | 206.807 | 2026-07-27 |
| WENTWORTH TIMOTHY C | director | 2026-07-01 | A-Award | 0 | 2026-07-02 |
| KUPPUSAMY KARTHIK | officer: SVP, Clinical Solutions | 2026-06-04 | M-Exempt | 121.805 | 2026-06-08 |
| KUPPUSAMY KARTHIK | officer: SVP, Clinical Solutions | 2026-06-04 | M-Exempt | 127.725 | 2026-06-08 |
| KUPPUSAMY KARTHIK | officer: SVP, Clinical Solutions | 2026-06-04 | S-Sale | 200 | 2026-06-08 |
| KUPPUSAMY KARTHIK | officer: SVP, Clinical Solutions | 2026-06-04 | M-Exempt | 127.725 | 2026-06-08 |
| KUPPUSAMY KARTHIK | officer: SVP, Clinical Solutions | 2026-06-04 | M-Exempt | 121.805 | 2026-06-08 |
| Davis J. E. | director, officer: CEO and President | 2026-06-01 | S-Sale | 194.14 | 2026-06-02 |
| CARTER ROBERT B | director | 2026-05-20 | A-Award | 0 | 2026-05-21 |
| Gregg Vicky B | director | 2026-05-20 | A-Award | 0 | 2026-05-21 |
| Diaz Luis | director | 2026-05-20 | A-Award | 0 | 2026-05-21 |
| MAIN TIMOTHY L | director | 2026-05-20 | A-Award | 0 | 2026-05-21 |
| WENTWORTH TIMOTHY C | director | 2026-05-20 | A-Award | 0 | 2026-05-21 |
| Doi Tracey | director | 2026-05-20 | A-Award | 0 | 2026-05-21 |
| RING TIMOTHY M | director | 2026-05-20 | A-Award | 0 | 2026-05-21 |
| Lassiter Wright III | director | 2026-05-20 | A-Award | 0 | 2026-05-21 |
| MORRISON DENISE M | director | 2026-05-20 | A-Award | 0 | 2026-05-21 |
| PFEIFFER GARY M | director | 2026-05-20 | A-Award | 0 | 2026-05-21 |
| SAMAD SAM | officer: Executive Vice President & CFO | 2026-04-20 | A-Award | 194.698 | 2026-04-24 |
| Plewman Patrick | officer: SVP for Diagnostic Services | 2026-04-20 | L-Small | 194.699 | 2026-04-24 |
| Gregg Vicky B | director | 2026-04-20 | A-Award | 194.698 | 2026-04-24 |
| CARTER ROBERT B | director | 2026-04-20 | L-Small | 194.699 | 2026-04-24 |
| Lassiter Wright III | director | 2026-04-20 | L-Small | 194.699 | 2026-04-24 |
| KUPPUSAMY KARTHIK | officer: SVP, Clinical Solutions | 2026-04-20 | L-Small | 194.699 | 2026-04-24 |
| DELANEY MARK E | officer: SVP & Chief Commercial Officer | 2026-04-20 | L-Small | 194.696 | 2026-04-24 |
| WENTWORTH TIMOTHY C | director | 2026-04-01 | A-Award | 0 | 2026-04-02 |
| WENTWORTH TIMOTHY C | director | 2026-03-09 | A-Award | 0 | 2026-03-11 |
| WENTWORTH TIMOTHY C | director: | 2026-03-09 | 0 | 2026-03-11 | |
| SAMAD SAM | officer: Executive Vice President & CFO | 2026-03-04 | A-Award | 204.86 | 2026-03-06 |
| SAMAD SAM | officer: Executive Vice President & CFO | 2026-03-04 | F-InKind | 204.86 | 2026-03-06 |
| Doherty Catherine T. | officer: EVP, Regional Businesses | 2026-03-04 | A-Award | 204.86 | 2026-03-06 |
| Doherty Catherine T. | officer: EVP, Regional Businesses | 2026-03-04 | F-InKind | 204.86 | 2026-03-06 |
| Doherty Catherine T. | officer: EVP, Regional Businesses | 2026-03-05 | S-Sale | 206.21 | 2026-03-06 |
| DELANEY MARK E | officer: SVP & Chief Commercial Officer | 2026-03-04 | A-Award | 204.86 | 2026-03-06 |
| DELANEY MARK E | officer: SVP & Chief Commercial Officer | 2026-03-04 | F-InKind | 204.86 | 2026-03-06 |
| PREVOZNIK MICHAEL E | officer: SVP & General Counsel | 2026-03-04 | A-Award | 204.86 | 2026-03-06 |
| PREVOZNIK MICHAEL E | officer: SVP & General Counsel | 2026-03-04 | F-InKind | 204.86 | 2026-03-06 |
| PREVOZNIK MICHAEL E | officer: SVP & General Counsel | 2026-03-05 | S-Sale | 206.21 | 2026-03-06 |
| Davis J. E. | director, officer: CEO and President | 2026-03-04 | A-Award | 204.86 | 2026-03-06 |
| Davis J. E. | director, officer: CEO and President | 2026-03-04 | F-InKind | 204.86 | 2026-03-06 |
| Plewman Patrick | officer: SVP for Diagnostic Services | 2026-03-04 | A-Award | 204.86 | 2026-03-06 |
| Plewman Patrick | officer: SVP for Diagnostic Services | 2026-03-04 | F-InKind | 204.86 | 2026-03-06 |
| Plewman Patrick | officer: SVP for Diagnostic Services | 2026-03-05 | S-Sale | 206.21 | 2026-03-06 |
| Deppe Michael J | officer: SVP, Corp. Controller & CAO | 2026-03-04 | A-Award | 204.86 | 2026-03-06 |
| Deppe Michael J | officer: SVP, Corp. Controller & CAO | 2026-03-04 | F-InKind | 204.86 | 2026-03-06 |
| KUPPUSAMY KARTHIK | officer: SVP, Clinical Solutions | 2026-03-04 | A-Award | 204.86 | 2026-03-06 |
| KUPPUSAMY KARTHIK | officer: SVP, Clinical Solutions | 2026-03-04 | S-Sale | 204.86 | 2026-03-06 |
| Doherty Catherine T. | officer: EVP, Regional Businesses | 2026-03-02 | F-InKind | 204.86 | 2026-03-04 |
| Doherty Catherine T. | officer: EVP, Regional Businesses | 2026-03-03 | S-Sale | 207.73 | 2026-03-04 |
| SAMAD SAM | officer: Executive Vice President & CFO | 2026-03-02 | F-InKind | 204.86 | 2026-03-04 |
| PREVOZNIK MICHAEL E | officer: SVP & General Counsel | 2026-03-02 | F-InKind | 204.86 | 2026-03-04 |
| PREVOZNIK MICHAEL E | officer: SVP & General Counsel | 2026-03-03 | S-Sale | 207.73 | 2026-03-04 |
| Davis J. E. | director, officer: CEO and President | 2026-03-02 | F-InKind | 204.86 | 2026-03-04 |
| Davis J. E. | director, officer: CEO and President | 2026-03-02 | S-Sale | 212.52 | 2026-03-04 |
| Plewman Patrick | officer: SVP for Diagnostic Services | 2026-03-02 | F-InKind | 204.86 | 2026-03-04 |
| Plewman Patrick | officer: SVP for Diagnostic Services | 2026-03-03 | S-Sale | 207.73 | 2026-03-04 |
| KUPPUSAMY KARTHIK | officer: SVP, Clinical Solutions | 2026-03-02 | F-InKind | 204.86 | 2026-03-04 |
| DELANEY MARK E | officer: SVP & Chief Commercial Officer | 2026-03-02 | F-InKind | 204.86 | 2026-03-04 |
| Deppe Michael J | officer: SVP, Corp. Controller & CAO | 2026-03-02 | F-InKind | 204.86 | 2026-03-04 |
| Plewman Patrick | officer: SVP for Diagnostic Services | 2026-02-18 | A-Award | 0 | 2026-02-20 |
| Plewman Patrick | officer: SVP for Diagnostic Services | 2026-02-18 | F-InKind | 210.01 | 2026-02-20 |
| Plewman Patrick | officer: SVP for Diagnostic Services | 2026-02-18 | F-InKind | 206.99 | 2026-02-20 |
| Plewman Patrick | officer: SVP for Diagnostic Services | 2026-02-19 | S-Sale | 204.83 | 2026-02-20 |
| Plewman Patrick | officer: SVP for Diagnostic Services | 2026-02-18 | A-Award | 204.96 | 2026-02-20 |
| SAMAD SAM | officer: Executive Vice President & CFO | 2026-02-18 | A-Award | 0 | 2026-02-20 |
| SAMAD SAM | officer: Executive Vice President & CFO | 2026-02-18 | F-InKind | 210.01 | 2026-02-20 |
| SAMAD SAM | officer: Executive Vice President & CFO | 2026-01-28 | A-Award | 183.514 | 2026-02-20 |
| SAMAD SAM | officer: Executive Vice President & CFO | 2026-02-18 | F-InKind | 206.99 | 2026-02-20 |
| SAMAD SAM | officer: Executive Vice President & CFO | 2026-02-18 | A-Award | 204.96 | 2026-02-20 |
| PREVOZNIK MICHAEL E | officer: SVP & General Counsel | 2026-02-18 | A-Award | 0 | 2026-02-20 |
| PREVOZNIK MICHAEL E | officer: SVP & General Counsel | 2026-02-18 | F-InKind | 210.01 | 2026-02-20 |
| PREVOZNIK MICHAEL E | officer: SVP & General Counsel | 2026-02-18 | F-InKind | 206.99 | 2026-02-20 |
| PREVOZNIK MICHAEL E | officer: SVP & General Counsel | 2026-02-19 | S-Sale | 204.83 | 2026-02-20 |
| PREVOZNIK MICHAEL E | officer: SVP & General Counsel | 2026-02-18 | A-Award | 204.96 | 2026-02-20 |
| Davis J. E. | director, officer: CEO and President | 2026-02-18 | A-Award | 0 | 2026-02-20 |
| Davis J. E. | director, officer: CEO and President | 2026-02-18 | F-InKind | 210.01 | 2026-02-20 |
| Davis J. E. | director, officer: CEO and President | 2026-02-18 | F-InKind | 206.99 | 2026-02-20 |
| Davis J. E. | director, officer: CEO and President | 2026-02-18 | A-Award | 204.96 | 2026-02-20 |
| Doherty Catherine T. | officer: EVP, Regional Businesses | 2026-02-18 | A-Award | 0 | 2026-02-20 |
| Doherty Catherine T. | officer: EVP, Regional Businesses | 2026-02-18 | F-InKind | 210.01 | 2026-02-20 |
| Doherty Catherine T. | officer: EVP, Regional Businesses | 2026-02-18 | F-InKind | 206.99 | 2026-02-20 |
| Doherty Catherine T. | officer: EVP, Regional Businesses | 2026-02-19 | S-Sale | 204.83 | 2026-02-20 |
| Doherty Catherine T. | officer: EVP, Regional Businesses | 2026-02-18 | A-Award | 204.96 | 2026-02-20 |
| KUPPUSAMY KARTHIK | officer: SVP, Clinical Solutions | 2026-01-28 | L-Small | 183.516 | 2026-02-20 |
| KUPPUSAMY KARTHIK | officer: SVP, Clinical Solutions | 2026-02-18 | A-Award | 0 | 2026-02-20 |
| KUPPUSAMY KARTHIK | officer: SVP, Clinical Solutions | 2026-02-18 | A-Award | 204.96 | 2026-02-20 |
| KUPPUSAMY KARTHIK | officer: SVP, Clinical Solutions | 2026-02-18 | F-InKind | 210.01 | 2026-02-20 |
| KUPPUSAMY KARTHIK | officer: SVP, Clinical Solutions | 2026-02-18 | F-InKind | 206.99 | 2026-02-20 |
| DELANEY MARK E | officer: SVP & Chief Commercial Officer | 2026-02-18 | A-Award | 0 | 2026-02-20 |
| DELANEY MARK E | officer: SVP & Chief Commercial Officer | 2026-02-18 | F-InKind | 210.01 | 2026-02-20 |
| DELANEY MARK E | officer: SVP & Chief Commercial Officer | 2026-01-28 | L-Small | 183.51 | 2026-02-20 |
| DELANEY MARK E | officer: SVP & Chief Commercial Officer | 2026-02-18 | F-InKind | 206.99 | 2026-02-20 |
| DELANEY MARK E | officer: SVP & Chief Commercial Officer | 2026-02-18 | A-Award | 204.96 | 2026-02-20 |